WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 2 fonti

ICMR transfers indigenous cervical cancer drug and vaccine technologies to Emcure and Biological E

ICMR has licensed a cervical cancer drug candidate to Emcure and two vaccine technologies to Biological E to accelerate affordable healthcare innovations.

Raccontata dathehindubusinessline.comeconomictimes.indiatimes.com

Confronto fonti

2 prospettive sulla stessa storia
AI · summaries
thehindubusinessline.comStai leggendo1 g fa

ICMR transfers indigenous cervical cancer drug and vaccine technologies to Emcure and Biological E

ICMR has licensed a cervical cancer drug candidate to Emcure and two vaccine technologies to Biological E to accelerate affordable healthcare innovations.

originale
economictimes.indiatimes.com1 g fa

ICMR licenses cancer, vaccine technologies to Emcure, Biological E

The Indian Council of Medical Research has licensed three new biomedical technologies. These innovations aim to advance cancer treatment and infectious disease protection. One drug candidate targets precancerous…

Timeline cronologica

  1. martedì 21 luglio 2026·thehindubusinessline.com

    ICMR transfers indigenous cervical cancer drug and vaccine technologies to Emcure and Biological E

    ICMR has licensed a cervical cancer drug candidate to Emcure and two vaccine technologies to Biological E to accelerate affordable healthcare innovations.

  2. martedì 21 luglio 2026·economictimes.indiatimes.com

    ICMR licenses cancer, vaccine technologies to Emcure, Biological E

    The Indian Council of Medical Research has licensed three new biomedical technologies. These innovations aim to advance cancer treatment and infectious disease protection. One…

Leggi questa versione →
originale